Renal anemia and hyperphosphatemia are both common complications associated with chronic kidney disease (CKD). Phosphate binders are frequently prescribed to prevent intestinal absorption of dietary phosphate and reduce serum phosphorous levels. However, iron-based phosphate binders represent a new class that could provide a dual benefit through reducing serum phosphorous levels while releasing iron to improve [...]The post Ferric Citrate: Killing Two Birds with One Stone in CKD? appeared first on DRG.
